Your browser doesn't support javascript.
loading
Prevalence of osteoporosis in patients with nephrolithiasis and vice versa: a cumulative analysis.
Jia, Shunjie; Liao, Jian; Wang, Yucheng; Zheng, Wenbiao; Jin, Jinghua; Xu, Weifang; Zheng, Qi.
Affiliation
  • Jia S; Department of Orthopedics, Taizhou Municipal Hospital, Taizhou, Zhejiang, China.
  • Liao J; Department of Nephrology, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, Zhejiang, China.
  • Wang Y; Department of Orthopedics, Taizhou Municipal Hospital, Taizhou, Zhejiang, China.
  • Zheng W; Department of Orthopedics, Taizhou Municipal Hospital, Taizhou, Zhejiang, China.
  • Jin J; Department of Orthopedics, Taizhou Municipal Hospital, Taizhou, Zhejiang, China.
  • Xu W; Department of Orthopedics, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China.
  • Zheng Q; Department of Orthopedics, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China.
Front Endocrinol (Lausanne) ; 14: 1180183, 2023.
Article in En | MEDLINE | ID: mdl-37469974
Purpose: Nephrolithiasis is thought to be a risk factor for osteoporosis, but data assessing if osteoporosis predisposes to the risk of nephrolithiasis are lacking. The present study aims to investigate whether patients with nephrolithiasis have a prominently higher prevalence of osteoporosis than the controls and vice versa via a cumulative analysis. Methods: Four databases were used to detect the eligible studies. We calculated the relative risk (RR) with a 95% confidence interval (CI) to assess the combined effect. The methodologies for conducting this study followed the PRISMA guidelines and were registered in the PROSPERO (ID: CRD42023395875). Results: Nine case-control or cohort studies with a total of 454,464 participants were finally included. Combined results indicated that there was a significantly higher prevalence of osteoporosis in patients with nephrolithiasis as compared to the general population without nephrolithiasis (overall RR from six studies= 1.204, 95%CI: 1.133 to 1.28, P< 0.001; heterogeneity: I2 = 34.8%, P= 0.162). Conversely, osteoporosis was significantly correlated to an increased risk of nephrolithiasis as compared to the controls without osteoporosis (overall RR from four studies= 1.505, 95%CI: 1.309 to 1.731, P< 0.001; I2 = 89.8%, P< 0.001). Sensitivity analysis on the two categories validated the above findings. No significant publication bias was identified in this study. Conclusions: The present study highlighted a significantly high prevalence of osteoporosis in patients with nephrolithiasis and vice versa. This reciprocal association reminded the clinicians to conduct a regular follow-up assessment when managing patients with nephrolithiasis or osteoporosis, especially for the elderly. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/#searchadvanced, identifier CRD42023395875.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Kidney Calculi Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Kidney Calculi Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland